25 XP   0   0   10

Novo Integrated Sciences Inc
Buy, Hold or Sell?

Let's analyse Novo Integrated Sciences Inc together

PenkeI guess you are interested in Novo Integrated Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Novo Integrated Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Novo Integrated Sciences Inc

I send you an email if I find something interesting about Novo Integrated Sciences Inc.

Quick analysis of Novo Integrated Sciences Inc (30 sec.)










What can you expect buying and holding a share of Novo Integrated Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$1.38
Expected worth in 1 year
$2.24
How sure are you?
52.5%

+ What do you gain per year?

Total Gains per Share
$0.86
Return On Investment
167.3%

For what price can you sell your share?

Current Price per Share
$0.52
Expected price per share
$0.43 - $0.82
How sure are you?
50%

1. Valuation of Novo Integrated Sciences Inc (5 min.)




Live pricePrice per Share (EOD)

$0.52

Intrinsic Value Per Share

$-1.97 - $-0.84

Total Value Per Share

$-0.59 - $0.54

2. Growth of Novo Integrated Sciences Inc (5 min.)




Is Novo Integrated Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$24.4m$32.9m-$7.3m-28.8%

How much money is Novo Integrated Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.1m-$8.7m$5.6m181.2%
Net Profit Margin-104.4%-8.7%--

How much money comes from the company's main activities?

3. Financial Health of Novo Integrated Sciences Inc (5 min.)




4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#145 / 186

Most Revenue
#173 / 186

Most Profit
#144 / 186

Most Efficient
#179 / 186

What can you expect buying and holding a share of Novo Integrated Sciences Inc? (5 min.)

Welcome investor! Novo Integrated Sciences Inc's management wants to use your money to grow the business. In return you get a share of Novo Integrated Sciences Inc.

What can you expect buying and holding a share of Novo Integrated Sciences Inc?

First you should know what it really means to hold a share of Novo Integrated Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Novo Integrated Sciences Inc is $0.515. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Novo Integrated Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Novo Integrated Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.38. Based on the TTM, the Book Value Change Per Share is $0.22 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.49 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Novo Integrated Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.18-34.6%-0.18-34.0%-0.18-34.5%-0.10-19.0%-0.06-10.9%
Usd Book Value Change Per Share0.000.0%0.2241.8%-0.49-94.6%0.0713.1%0.047.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.8%
Usd Total Gains Per Share0.000.0%0.2241.8%-0.49-94.6%0.0713.1%0.047.7%
Usd Price Per Share1.20-0.40-1.34-1.14-0.75-
Price to Earnings Ratio-1.68--0.60--1.90--9.27--13.15-
Price-to-Total Gains Ratio-1.58--96.37--28.53-153.54-
Price to Book Ratio0.87-0.29-1.05-0.75-41.74-
Price-to-Total Gains Ratio-1.58--96.37--28.53-153.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.515
Number of shares1941
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.220.07
Usd Total Gains Per Share0.220.07
Gains per Quarter (1941 shares)418.20131.13
Gains per Year (1941 shares)1,672.81524.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10167316630525515
2033463336010491040
3050185009015741565
4066916682020982090
5083648355026232615
601003710028031473140
701171011701036723665
801338213374041964190
901505515047047214715
1001672816720052455240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.039.00.02.5%1.075.00.01.3%
Book Value Change Per Share1.02.01.025.0%4.07.01.033.3%10.09.01.050.0%19.015.06.047.5%25.037.014.032.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%2.00.038.05.0%2.00.074.02.6%
Total Gains per Share1.02.01.025.0%4.07.01.033.3%10.09.01.050.0%21.014.05.052.5%27.036.013.035.5%

Fundamentals of Novo Integrated Sciences Inc

About Novo Integrated Sciences Inc

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors. Further, it provides medical technology services, such as telemedicine and remote patient monitoring; develops and distributes personalized health and wellness product solutions; and operates corporate-owned clinics. The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017. The company is headquartered in Bellevue, Washington. Novo Integrated Sciences, Inc. is a subsidiary of ALMC-ASAP Holdings, Inc.

Fundamental data was last updated by Penke on 2024-04-11 16:23:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Novo Integrated Sciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Novo Integrated Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Novo Integrated Sciences Inc to the Medical Care Facilities industry mean.
  • A Net Profit Margin of -95.7% means that $-0.96 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Novo Integrated Sciences Inc:

  • The MRQ is -95.7%. The company is making a huge loss. -2
  • The TTM is -104.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-95.7%TTM-104.4%+8.7%
TTM-104.4%YOY-8.7%-95.7%
TTM-104.4%5Y-58.8%-45.6%
5Y-58.8%10Y-32.5%-26.3%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-95.7%2.5%-98.2%
TTM-104.4%2.5%-106.9%
YOY-8.7%3.8%-12.5%
5Y-58.8%3.2%-62.0%
10Y-32.5%3.7%-36.2%
1.1.2. Return on Assets

Shows how efficient Novo Integrated Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Novo Integrated Sciences Inc to the Medical Care Facilities industry mean.
  • -8.9% Return on Assets means that Novo Integrated Sciences Inc generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Novo Integrated Sciences Inc:

  • The MRQ is -8.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.9%TTM-8.7%-0.2%
TTM-8.7%YOY-19.4%+10.7%
TTM-8.7%5Y-7.5%-1.2%
5Y-7.5%10Y-146.6%+139.1%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.9%0.8%-9.7%
TTM-8.7%0.6%-9.3%
YOY-19.4%1.1%-20.5%
5Y-7.5%0.9%-8.4%
10Y-146.6%1.2%-147.8%
1.1.3. Return on Equity

Shows how efficient Novo Integrated Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Novo Integrated Sciences Inc to the Medical Care Facilities industry mean.
  • -12.7% Return on Equity means Novo Integrated Sciences Inc generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Novo Integrated Sciences Inc:

  • The MRQ is -12.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.7%TTM-12.0%-0.7%
TTM-12.0%YOY-34.7%+22.7%
TTM-12.0%5Y-11.6%-0.4%
5Y-11.6%10Y-50.4%+38.7%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.7%2.2%-14.9%
TTM-12.0%2.2%-14.2%
YOY-34.7%2.7%-37.4%
5Y-11.6%2.3%-13.9%
10Y-50.4%2.8%-53.2%

1.2. Operating Efficiency of Novo Integrated Sciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Novo Integrated Sciences Inc is operating .

  • Measures how much profit Novo Integrated Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Novo Integrated Sciences Inc to the Medical Care Facilities industry mean.
  • An Operating Margin of -75.2% means the company generated $-0.75  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Novo Integrated Sciences Inc:

  • The MRQ is -75.2%. The company is operating very inefficient. -2
  • The TTM is -46.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-75.2%TTM-46.6%-28.6%
TTM-46.6%YOY-37.0%-9.7%
TTM-46.6%5Y-49.8%+3.1%
5Y-49.8%10Y-26.9%-22.9%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-75.2%6.6%-81.8%
TTM-46.6%6.6%-53.2%
YOY-37.0%7.3%-44.3%
5Y-49.8%6.6%-56.4%
10Y-26.9%8.0%-34.9%
1.2.2. Operating Ratio

Measures how efficient Novo Integrated Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 1.94 means that the operating costs are $1.94 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Novo Integrated Sciences Inc:

  • The MRQ is 1.937. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.931. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.937TTM1.931+0.005
TTM1.931YOY1.590+0.341
TTM1.9315Y1.542+0.389
5Y1.54210Y1.003+0.539
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9371.161+0.776
TTM1.9311.101+0.830
YOY1.5901.027+0.563
5Y1.5421.026+0.516
10Y1.0031.004-0.001

1.3. Liquidity of Novo Integrated Sciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Novo Integrated Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 0.56 means the company has $0.56 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Novo Integrated Sciences Inc:

  • The MRQ is 0.555. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.602. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.555TTM0.602-0.047
TTM0.602YOY0.996-0.394
TTM0.6025Y1.237-0.635
5Y1.23710Y1.268-0.031
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5551.288-0.733
TTM0.6021.308-0.706
YOY0.9961.342-0.346
5Y1.2371.385-0.148
10Y1.2681.427-0.159
1.3.2. Quick Ratio

Measures if Novo Integrated Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Novo Integrated Sciences Inc to the Medical Care Facilities industry mean.
  • A Quick Ratio of 0.24 means the company can pay off $0.24 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Novo Integrated Sciences Inc:

  • The MRQ is 0.238. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.264. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.238TTM0.264-0.026
TTM0.264YOY0.860-0.596
TTM0.2645Y1.001-0.737
5Y1.00110Y14.477-13.476
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2380.913-0.675
TTM0.2640.950-0.686
YOY0.8601.056-0.196
5Y1.0011.159-0.158
10Y14.4771.149+13.328

1.4. Solvency of Novo Integrated Sciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Novo Integrated Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Novo Integrated Sciences Inc to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.31 means that Novo Integrated Sciences Inc assets are financed with 31.1% credit (debt) and the remaining percentage (100% - 31.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Novo Integrated Sciences Inc:

  • The MRQ is 0.311. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.287. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.311TTM0.287+0.024
TTM0.287YOY0.415-0.128
TTM0.2875Y0.256+0.031
5Y0.25610Y2.266-2.010
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3110.518-0.207
TTM0.2870.546-0.259
YOY0.4150.522-0.107
5Y0.2560.564-0.308
10Y2.2660.529+1.737
1.4.2. Debt to Equity Ratio

Measures if Novo Integrated Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Novo Integrated Sciences Inc to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 44.6% means that company has $0.45 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Novo Integrated Sciences Inc:

  • The MRQ is 0.446. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.399. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.446TTM0.399+0.047
TTM0.399YOY0.714-0.314
TTM0.3995Y0.368+0.031
5Y0.36810Y1.756-1.388
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4460.912-0.466
TTM0.3990.952-0.553
YOY0.7141.078-0.364
5Y0.3681.231-0.863
10Y1.7561.261+0.495

2. Market Valuation of Novo Integrated Sciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Novo Integrated Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Novo Integrated Sciences Inc to the Medical Care Facilities industry mean.
  • A PE ratio of -1.68 means the investor is paying $-1.68 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Novo Integrated Sciences Inc:

  • The EOD is -0.723. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.685. Based on the earnings, the company is expensive. -2
  • The TTM is -0.599. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.723MRQ-1.685+0.962
MRQ-1.685TTM-0.599-1.086
TTM-0.599YOY-1.900+1.302
TTM-0.5995Y-9.266+8.667
5Y-9.26610Y-13.152+3.886
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-0.72311.880-12.603
MRQ-1.68510.761-12.446
TTM-0.59914.335-14.934
YOY-1.90011.894-13.794
5Y-9.26618.369-27.635
10Y-13.15220.381-33.533
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Novo Integrated Sciences Inc:

  • The EOD is -8.818. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -20.548. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.063. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.818MRQ-20.548+11.729
MRQ-20.548TTM-6.063-14.485
TTM-6.063YOY1.257-7.321
TTM-6.0635Y-29.380+23.317
5Y-29.38010Y-26.913-2.467
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-8.8188.735-17.553
MRQ-20.5487.737-28.285
TTM-6.0637.737-13.800
YOY1.2576.598-5.341
5Y-29.3807.279-36.659
10Y-26.9135.720-32.633
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Novo Integrated Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 0.87 means the investor is paying $0.87 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Novo Integrated Sciences Inc:

  • The EOD is 0.373. Based on the equity, the company is cheap. +2
  • The MRQ is 0.869. Based on the equity, the company is cheap. +2
  • The TTM is 0.286. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.373MRQ0.869-0.496
MRQ0.869TTM0.286+0.584
TTM0.286YOY1.052-0.766
TTM0.2865Y0.745-0.460
5Y0.74510Y41.741-40.995
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD0.3731.873-1.500
MRQ0.8691.861-0.992
TTM0.2861.942-1.656
YOY1.0522.124-1.072
5Y0.7452.374-1.629
10Y41.7412.553+39.188
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Novo Integrated Sciences Inc.

3.1. Institutions holding Novo Integrated Sciences Inc

Institutions are holding 5.586% of the shares of Novo Integrated Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc1.644802919212919210
2023-12-31Vanguard Group Inc1.406502496322496320
2023-12-31Geode Capital Management, LLC0.720801279291279290
2023-12-31Virtu Financial LLC0.48570.005686197861970
2023-12-31State Street Corporation0.1875033280332800
2023-12-31Northern Trust Corp0.1572027905279050
2023-12-31JANE STREET GROUP, LLC0.0909016132161320
2023-12-31XTX Topco Ltd0.06970.002212368123680
2023-12-31UBS Group AG0.0682012113121130
2023-12-31Tower Research Capital LLC0.05070.0001899889980
2023-12-31Royal Bank of Canada0.04240752875280
2023-12-31Bank of America Corp0.002103703700
2023-12-31Wells Fargo & Co0.000601131130
2023-12-31JPMorgan Chase & Co0.0001026260
2023-12-31Morgan Stanley - Brokerage Accounts00550
2023-09-30Axxcess Wealth Management, LLC000-55000-100
2023-09-30Cubist Systematic Strategies, LLC000-130130-100
2023-12-31CAMBRIDGE Invest RESEARCH ADVISORS, INC.000-1450-100
Total 4.92720.0079874517+687937+78.7%

3.2. Funds holding Novo Integrated Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BlackRock Extended Mkt Composite0.2110.00083744493744490
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.92280.000116377700
2024-02-29Vanguard Total Stock Mkt Idx Inv0.434407710500
2024-02-29Fidelity Extended Market Index0.37630.000166780-324-0.4828
2024-03-31BlackRock Extended Equity Market K0.18410.000132679120.0367
2024-02-29Fidelity Series Total Market Index0.112902003300
2024-02-29Fidelity Total Market Index0.105701875900
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0890.00021579200
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.07150.000212683240.1896
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06820.000212113322436.2695
2023-12-31Northern Trust Extended Eq Market Idx0.06820.000212113322436.2695
2024-02-29Fidelity Nasdaq Composite Index0.056901009700
2024-02-29Vanguard U.S. Eq Idx £ Acc0.04930875000
2024-02-29Spartan Total Market Index Pool E0.0440781400
2024-02-29Spartan Extended Market Index Pool E0.02450.000143523248.0437
2024-03-31Extended Equity Market Fund M0.02270.00014031-8-0.1981
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00290.000251120.3929
2024-03-31State St US Extended Mkt Indx NL Cl C0.002035000
2023-12-31SSgA U.S. Extended Market Index Class I0.002035000
2024-02-29State St US Ttl Mkt Indx SL Cl I0.0007013000
Total 2.84910.0023842668+380927+45.2%

3.3. Insider Transactions

Insiders are holding 7.442% of the shares of Novo Integrated Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-04-19Robert Letterio OlivaBUY50022.3

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Novo Integrated Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.215-100%-0.4870%0.068-100%0.036-100%
Book Value Per Share--1.3801.440-4%1.559-11%1.579-13%0.774+78%
Current Ratio--0.5550.602-8%0.996-44%1.237-55%1.268-56%
Debt To Asset Ratio--0.3110.287+8%0.415-25%0.256+22%2.266-86%
Debt To Equity Ratio--0.4460.399+12%0.714-38%0.368+21%1.756-75%
Dividend Per Share----0%-0%-0%0.004-100%
Eps---0.178-0.175-2%-0.1780%-0.098-45%-0.056-69%
Free Cash Flow Per Share---0.015-0.032+119%-0.079+441%-0.030+106%-0.018+26%
Free Cash Flow To Equity Per Share--0.0120.000+101%0.039-70%0.012-5%0.007+67%
Gross Profit Margin--1.0021.001+0%1.0020%1.0020%1.025-2%
Intrinsic Value_10Y_max---0.841--------
Intrinsic Value_10Y_min---1.967--------
Intrinsic Value_1Y_max---0.075--------
Intrinsic Value_1Y_min---0.184--------
Intrinsic Value_3Y_max---0.233--------
Intrinsic Value_3Y_min---0.566--------
Intrinsic Value_5Y_max---0.399--------
Intrinsic Value_5Y_min---0.963--------
Market Cap9140374.500-133%21297960.0007093551.803+200%30728658.794-31%22605087.729-6%14624184.188+46%
Net Profit Margin---0.957-1.044+9%-0.087-91%-0.588-39%-0.325-66%
Operating Margin---0.752-0.466-38%-0.370-51%-0.498-34%-0.269-64%
Operating Ratio--1.9371.931+0%1.590+22%1.542+26%1.003+93%
Pb Ratio0.373-133%0.8690.286+204%1.052-17%0.745+17%41.741-98%
Pe Ratio-0.723+57%-1.685-0.599-64%-1.900+13%-9.266+450%-13.152+681%
Price Per Share0.515-133%1.2000.400+200%1.339-10%1.138+5%0.751+60%
Price To Free Cash Flow Ratio-8.818+57%-20.548-6.063-70%1.257-1734%-29.380+43%-26.913+31%
Quick Ratio--0.2380.264-10%0.860-72%1.001-76%14.477-98%
Return On Assets---0.089-0.087-3%-0.194+118%-0.075-16%-1.466+1550%
Return On Equity---0.127-0.120-6%-0.347+172%-0.116-9%-0.504+295%
Total Gains Per Share---0.215-100%-0.4870%0.068-100%0.040-100%
Usd Book Value--24499075.00025563130.000-4%32918838.000-26%30429151.800-19%14939853.825+64%
Usd Book Value Change Per Share---0.215-100%-0.4870%0.068-100%0.036-100%
Usd Book Value Per Share--1.3801.440-4%1.559-11%1.579-13%0.774+78%
Usd Dividend Per Share----0%-0%-0%0.004-100%
Usd Eps---0.178-0.175-2%-0.1780%-0.098-45%-0.056-69%
Usd Free Cash Flow---259126.000-568357.000+119%-1368262.500+428%-542467.150+109%-331760.800+28%
Usd Free Cash Flow Per Share---0.015-0.032+119%-0.079+441%-0.030+106%-0.018+26%
Usd Free Cash Flow To Equity Per Share--0.0120.000+101%0.039-70%0.012-5%0.007+67%
Usd Market Cap9140374.500-133%21297960.0007093551.803+200%30728658.794-31%22605087.729-6%14624184.188+46%
Usd Price Per Share0.515-133%1.2000.400+200%1.339-10%1.138+5%0.751+60%
Usd Profit---3160454.000-3109898.250-2%-8744510.250+177%-3116395.400-1%-1673341.375-47%
Usd Revenue--3303297.0003114009.000+6%2998822.500+10%2555479.650+29%1756013.600+88%
Usd Total Gains Per Share---0.215-100%-0.4870%0.068-100%0.040-100%
 EOD+2 -5MRQTTM+13 -20YOY+12 -175Y+5 -2810Y+17 -18

4.2. Fundamental Score

Let's check the fundamental score of Novo Integrated Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.723
Price to Book Ratio (EOD)Between0-10.373
Net Profit Margin (MRQ)Greater than0-0.957
Operating Margin (MRQ)Greater than0-0.752
Quick Ratio (MRQ)Greater than10.238
Current Ratio (MRQ)Greater than10.555
Debt to Asset Ratio (MRQ)Less than10.311
Debt to Equity Ratio (MRQ)Less than10.446
Return on Equity (MRQ)Greater than0.15-0.127
Return on Assets (MRQ)Greater than0.05-0.089
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Novo Integrated Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.327
Ma 20Greater thanMa 500.491
Ma 50Greater thanMa 1000.575
Ma 100Greater thanMa 2000.747
OpenGreater thanClose0.500
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-11-30. Currency in USD. All numbers in thousands.

Summary
Total Assets35,563
Total Liabilities11,064
Total Stockholder Equity24,816
 As reported
Total Liabilities 11,064
Total Stockholder Equity+ 24,816
Total Assets = 35,563

Assets

Total Assets35,563
Total Current Assets4,388
Long-term Assets31,175
Total Current Assets
Cash And Cash Equivalents 416
Net Receivables 1,467
Inventory 1,107
Other Current Assets 346
Total Current Assets  (as reported)4,388
Total Current Assets  (calculated)3,337
+/- 1,052
Long-term Assets
Property Plant Equipment 7,374
Goodwill 7,582
Intangible Assets 16,219
Long-term Assets  (as reported)31,175
Long-term Assets  (calculated)31,175
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,905
Long-term Liabilities3,159
Total Stockholder Equity24,816
Total Current Liabilities
Short-term Debt 2,713
Short Long Term Debt 2,569
Accounts payable 3,514
Other Current Liabilities 1,643
Total Current Liabilities  (as reported)7,905
Total Current Liabilities  (calculated)10,439
+/- 2,534
Long-term Liabilities
Long term Debt 64
Capital Lease Obligations 2,008
Long-term Liabilities  (as reported)3,159
Long-term Liabilities  (calculated)2,072
+/- 1,087
Total Stockholder Equity
Common Stock16
Retained Earnings -67,033
Accumulated Other Comprehensive Income -357
Other Stockholders Equity 92,191
Total Stockholder Equity (as reported)24,816
Total Stockholder Equity (calculated)24,816
+/-0
Other
Capital Stock17
Cash and Short Term Investments 416
Common Stock Shares Outstanding 15,759
Current Deferred Revenue35
Liabilities and Stockholders Equity 35,563
Net Debt 4,055
Net Invested Capital 26,216
Net Working Capital -4,107
Property Plant and Equipment Gross 8,489
Short Long Term Debt Total 4,472



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-302013-08-312013-05-312013-02-282012-11-302012-08-312012-05-312012-02-292011-11-302011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302009-08-312009-05-312009-02-282008-11-302008-08-312008-05-312008-02-292007-11-302007-08-312007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312005-05-312005-02-282004-08-31
> Total Assets 
-25
100
20
2
15
15
106
28
4
4
38
83
36
36
120
86
20
20
63
307
622
622
470
478
1,187
1,187
178
164
26
26
274
275
35
35
22
379
358
358
201
133
23
23
22
22
28
28
31
27
70
70
37
5,514
5,514
5,072
4,840
4,743
5,062
29,081
31,682
32,273
32,104
36,640
36,572
35,391
35,391
34,857
42,228
61,958
61,958
70,320
71,793
40,873
37,749
36,489
35,745
35,563
35,563
35,56335,56335,74536,48937,74940,87371,79370,32061,95861,95842,22834,85735,39135,39136,57236,64032,10432,27331,68229,0815,0624,7434,8405,0725,5145,514377070273128282222232313320135835837922353527527426261641781,1871,187478470622622307632020861203636833844281061515220100-25
   > Total Current Assets 
-25
3
18
0
13
13
103
25
1
1
9
58
5
5
98
68
7
7
54
298
614
614
359
374
237
237
127
113
19
19
56
59
17
17
7
79
345
345
190
124
2
2
8
9
14
14
17
13
56
56
24
3,650
3,650
3,005
2,778
2,569
2,841
4,503
4,588
4,099
4,168
4,114
3,929
4,295
4,295
3,605
10,832
11,134
11,134
19,015
20,079
5,732
4,457
4,051
3,998
4,388
4,388
4,3884,3883,9984,0514,4575,73220,07919,01511,13411,13410,8323,6054,2954,2953,9294,1144,1684,0994,5884,5032,8412,5692,7783,0053,6503,6502456561317141498221241903453457971717595619191131272372373743596146142985477689855589112510313130183-25
       Cash And Cash Equivalents 
-25
3
13
0
13
13
26
13
1
1
5
54
3
3
48
46
3
3
54
269
604
604
341
347
128
128
7
9
12
12
12
24
6
6
0
1
3
3
-2,250
6
2
2
8
9
14
14
17
13
54
54
15
1,897
1,897
1,037
864
676
929
2,374
2,478
2,084
1,932
1,209
1,394
2,068
2,068
1,698
8,367
8,293
8,293
15,944
12,677
2,179
879
610
464
416
416
4164164646108792,17912,67715,9448,2938,2938,3671,6982,0682,0681,3941,2091,9322,0842,4782,3749296768641,0371,8971,8971554541317141498226-2,2503310662412121297128128347341604604269543346483354511132613130133-25
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,862
1,501
1,501
1,642
1,601
1,731
1,763
1,966
1,960
1,765
1,934
2,548
2,171
2,035
2,035
1,491
2,102
2,283
2,283
2,234
5,166
2,103
2,014
924
1,328
2,223
1,467
1,4672,2231,3289242,0142,1035,1662,2342,2832,2832,1021,4912,0352,0352,1712,5481,9341,7651,9601,9661,7631,7311,6011,6421,5011,5012,86200000000000000000000000000000000000000000000000000
       Other Current Assets 
0
0
5
0
0
5
77
12
0
0
4
4
0
2
5
4
0
4
0
29
0
10
18
26
0
109
119
105
0
7
44
35
0
11
7
78
0
286
190
119
0
0
0
0
0
0
0
0
2
2
191
253
253
327
313
162
149
163
150
250
302
356
364
303
192
415
363
0
218
503
381
571
555
547
221
346
346
3463462215475555713815032180363415192303364356302250150163149162313327253253191220000000011919028607871103544701051191090261810029040452044001277500500
   > Long-term Assets 
0
97
2
2
2
2
4
3
3
3
29
25
31
31
22
18
0
13
9
9
8
8
111
104
950
950
52
51
7
7
218
216
18
18
15
300
13
13
10
9
21
21
14
14
0
14
14
14
14
14
14
0
1,864
2,067
2,062
2,174
2,221
24,578
27,094
28,175
27,936
32,526
32,643
31,096
31,096
31,252
31,396
50,825
50,825
51,305
51,714
35,141
33,292
32,439
31,747
31,175
31,175
31,17531,17531,74732,43933,29235,14151,71451,30550,82550,82531,39631,25231,09631,09632,64332,52627,93628,17527,09424,5782,2212,1742,0622,0671,86401414141414140141421219101313300151818216218775152950950104111889913018223131252933342222970
       Property Plant Equipment 
0
2
2
2
2
2
4
3
3
3
29
25
31
31
22
18
13
13
9
9
8
8
11
9
7
7
52
51
7
7
20
19
18
18
15
300
13
13
10
9
7
7
0
0
0
0
0
0
0
0
292
303
303
314
331
400
445
427
2,620
3,414
3,280
3,384
3,147
3,164
3,164
2,881
3,089
8,614
8,614
8,506
8,155
8,475
7,987
7,700
7,508
7,374
7,374
7,3747,3747,5087,7007,9878,4758,1558,5068,6148,6143,0892,8813,1643,1643,1473,3843,2803,4142,62042744540033131430330329200000000779101313300151818192077515277911889913131822313125293334222220
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
370
399
399
617
609
604
595
600
584
623
625
619
603
637
637
652
688
9,082
9,489
9,059
11,367
7,826
7,596
7,539
7,543
7,582
7,582
7,5827,5827,5437,5397,5967,82611,3679,0599,4899,08268865263763760361962562358460059560460961739939937000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
943
943
0
0
0
943
0
0
0
0
0
0
0
0
0
0
14
14
14
14
14
14
14
14
14
14
14
399
388
617
66
0
0
22,359
22,359
22,359
22,359
27,607
27,993
26,623
26,623
26,806
26,894
32,436
32,029
33,218
32,193
18,841
17,708
17,200
16,696
16,219
16,219
16,21916,21916,69617,20017,70818,84132,19333,21832,02932,43626,89426,80626,62326,62327,99327,60722,35922,35922,35922,359006661738839914141414141414141414140000000000943000943943000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
370
1,561
1,517
1,753
1,122
1,170
1,182
1,192
1,531
1,779
1,672
917
900
671
3,422
913
725
693
371
522
0
0
0
0
0
0
0
00000005223716937259133,4226719009171,6721,7791,5311,1921,1821,1701,1221,7531,5171,56137000000000000000000000000000000000000000000000000000
> Total Liabilities 
33
239
328
412
479
479
722
324
464
464
836
927
1,029
1,029
1,259
1,318
1,459
1,459
1,499
1,498
1,508
1,508
1,711
1,745
2,679
2,679
2,058
2,244
2,354
2,354
674
797
832
832
957
1,263
1,306
1,306
1,345
714
648
648
56
12
13
13
9
3
20
20
5
9,803
9,803
4,719
4,556
4,570
4,545
4,252
6,368
6,729
6,531
6,340
5,974
5,819
5,819
5,722
5,617
18,154
18,154
25,805
27,365
18,825
17,064
9,526
9,454
11,064
11,064
11,06411,0649,4549,52617,06418,82527,36525,80518,15418,1545,6175,7225,8195,8195,9746,3406,5316,7296,3684,2524,5454,5704,5564,7199,8039,8035202039131312566486487141,3451,3061,3061,2639578328327976742,3542,3542,2442,0582,6792,6791,7451,7111,5081,5081,4981,4991,4591,4591,3181,2591,0291,02992783646446432472247947941232823933
   > Total Current Liabilities 
33
239
328
412
477
477
625
323
462
462
834
925
687
687
863
933
1,021
458
1,090
119
206
206
276
236
1,082
1,082
153
141
141
141
173
214
242
242
243
206
558
558
442
373
341
341
56
12
13
13
9
3
20
20
5
4,274
4,274
3,064
2,922
3,346
3,340
3,037
4,579
3,028
2,948
2,662
2,530
2,600
2,600
3,658
3,524
8,464
8,464
11,554
12,730
14,075
12,565
6,178
6,209
7,905
7,905
7,9057,9056,2096,17812,56514,07512,73011,5548,4648,4643,5243,6582,6002,6002,5302,6622,9483,0284,5793,0373,3403,3462,9223,0644,2744,2745202039131312563413413734425585582062432422422141731411411411531,0821,0822362762062061191,0904581,02193386368768792583446246232362547747741232823933
       Short-term Debt 
0
2
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
1
1
1
1
1
1
1
1
1
1
1
8
9
21
67
97
97
60
28
385
385
235
235
215
215
0
0
0
0
0
0
0
0
4,775
13
13
6
6
382
376
380
1,967
508
519
544
615
83
1,175
2,041
1,632
0
5,519
7,857
8,152
9,691
0
2,383
2,726
0
2,713
2,71302,7262,38309,6918,1527,8575,51901,6322,0411,175836155445195081,9673803763826613134,77500000000215215235235385385286097976721981111111111101110000000000020
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,965
13
6
6
6
382
376
380
1,553
0
0
776
80
83
84
1,059
1,117
4,965
11,316
7,306
7,592
9,579
6,840
1,425
1,876
2,286
2,569
2,5692,2861,8761,4256,8409,5797,5927,30611,3164,9651,1171,059848380776001,553380376382666136,96500000000000000000000000000000000000000000000000000
       Accounts payable 
33
49
45
48
0
50
46
64
0
55
39
35
0
40
58
51
0
146
120
106
0
140
167
185
0
162
134
119
0
116
132
124
0
118
163
160
0
146
161
77
0
83
56
12
0
13
9
3
20
20
5
1,703
1,703
1,744
1,310
1,308
1,368
1,254
1,284
1,145
1,078
804
672
884
884
901
849
1,450
1,450
1,106
1,622
1,800
2,075
2,040
1,896
3,514
3,514
3,5143,5141,8962,0402,0751,8001,6221,1061,4501,4508499018848846728041,0781,1451,2841,2541,3681,3081,3101,7441,7031,703520203913012568307716114601601631180124132116011913416201851671400106120146051584003539550644650048454933
       Other Current Liabilities 
0
188
283
363
0
427
579
259
0
407
794
890
0
647
804
881
0
313
970
13
0
66
108
50
0
920
19
21
0
16
20
23
0
26
20
19
0
26
47
61
0
43
0
0
0
0
0
0
0
0
2,895
2,558
2,557
1,314
1,606
1,656
1,595
1,403
1,327
1,374
1,351
1,314
1,243
0
1,003
716
1,043
39
2,914
2,553
2,918
2,584
1,489
1,719
1,551
62
1,643
1,643621,5511,7191,4892,5842,9182,5532,914391,0437161,00301,2431,3141,3511,3741,3271,4031,5951,6561,6061,3142,5572,5582,8950000000043061472601920260232016021199200501086601397031308818046470890794407025957942703632831880
   > Long-term Liabilities 
0
51
45
48
2
2
97
2
2
2
2
2
342
342
396
385
0
1,001
409
1,379
1,302
1,302
1,435
1,509
1,597
1,597
1,905
2,104
2,213
2,213
500
583
590
590
714
1,057
748
748
903
341
308
308
56
12
0
13
9
3
0
20
372
0
5,529
1,654
1,634
1,224
1,205
1,216
1,790
3,702
3,582
3,677
3,444
3,219
3,219
2,064
2,094
9,690
9,690
14,251
14,634
4,751
4,499
3,348
3,245
3,159
3,159
3,1593,1593,2453,3484,4994,75114,63414,2519,6909,6902,0942,0643,2193,2193,4443,6773,5823,7021,7901,2161,2051,2241,6341,6545,52903722003913012563083083419037487481,0577145905905835002,2132,2132,1041,9051,5971,5971,5091,4351,3021,3021,3794091,00103853963423422222297224845510
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,500
1,480
1,497
1,499
0
1,403
1,393
0
0
0
0001,3931,40301,4991,4971,4801,5000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
85
-139
-308
-409
0
-463
-615
-297
0
-460
-798
-844
0
-992
-1,138
-1,232
0
-1,439
-1,436
-1,191
0
-886
-1,241
-1,267
0
-1,492
-1,879
-2,080
0
-2,328
-400
-522
0
-797
-935
-884
0
-948
-1,145
-580
0
-626
-34
10
0
15
22
24
50
50
32
-4,268
-4,268
379
310
201
551
24,866
25,351
25,584
25,614
30,342
30,642
29,621
29,621
29,188
36,671
43,864
43,864
44,551
44,373
22,305
20,948
27,251
26,567
24,816
24,816
24,81624,81626,56727,25120,94822,30544,37344,55143,86443,86436,67129,18829,62129,62130,64230,34225,61425,58425,35124,866551201310379-4,268-4,268325050242215010-34-6260-580-1,145-9480-884-935-7970-522-400-2,3280-2,080-1,879-1,4920-1,267-1,241-8860-1,191-1,436-1,4390-1,232-1,138-9920-844-798-4600-297-615-4630-409-308-13985
   Common Stock
85
11
12
12
0
12
12
13
0
13
15
17
0
17
19
20
0
22
29
36
0
40
43
45
0
46
53
54
0
57
67
67
0
69
124
253
0
268
341
356
0
18
22
22
0
22
22
22
23
23
23
202
202
215
215
208
208
223
224
224
224
232
233
235
23
24
26
27
27
29
31
31
40
140
145
0
16
160145140403131292727262423235233232224224224223208208215215202202232323222222022221803563412680253124690676757054534604543400362922020191701715130131212012121185
   Retained Earnings -67,033-67,033-63,873-62,375-57,754-53,818-31,391-27,581-20,969-20,969-19,030-18,618-16,507-16,507-12,283-12,185-11,680-11,592-11,670-11,571-11,451-11,200-11,042-10,824-9,092-9,092-22,425-22,388-22,388-22,346-22,308-22,223-22,223-22,188-22,175-19,453-19,453-19,124-18,915-18,419-18,419-18,227-18,057-17,531-17,531-17,366-17,167-16,371-16,371-15,954-15,453-14,133-14,133-13,673-13,423-11,564-11,564-10,679-10,043-9,292-9,292-8,941-8,673-8,309-8,309-7,456-6,970-5,839-5,839-5,321-4,760-4,374-4,374-4,095-3,976-3,6010
   Accumulated Other Comprehensive Income 
0
0
-170
-196
-3
-22
-167
-227
0
-207
-201
-736
-18
-185
-292
-231
0
0
-40
-40
-42
-42
-44
-46
-44
-44
-47
-47
-48
-48
-50
-51
-52
-52
-55
-56
-57
25
10
32
-30
50
0
0
-1
-1
0
0
0
0
1,559
-268
1,241
1,154
1,145
1,140
1,138
1,166
1,102
1,139
1,144
1,128
1,077
-506
1,200
1,253
1,376
0
991
1,002
1,016
0
0
-52
-173
0
-357
-3570-173-52001,0161,00299101,3761,2531,200-5061,0771,1281,1441,1391,1021,1661,1381,1401,1451,1541,241-2681,5590000-1-10050-30321025-57-56-55-52-52-51-50-48-48-47-47-44-44-46-44-42-42-40-4000-231-292-185-18-736-201-2070-227-167-22-3-196-17000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-08-31)

Gross Profit (+$)
totalRevenue11,738
Cost of Revenue-6,939
Gross Profit4,7994,799
 
Operating Income (+$)
Gross Profit4,799
Operating Expense-14,385
Operating Income-25,027-9,586
 
Operating Expense (+$)
Research Development0
Selling General Administrative14,365
Selling And Marketing Expenses21
Operating Expense14,38514,385
 
Net Interest Income (+$)
Interest Income9
Interest Expense-7,568
Other Finance Cost-2,451
Net Interest Income-5,109
 
Pretax Income (+$)
Operating Income-25,027
Net Interest Income-5,109
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-33,067-8,944
EBIT - interestExpense = -16,985
-32,872
-25,281
Interest Expense7,568
Earnings Before Interest and Taxes (EBIT)-9,417-25,499
Earnings Before Interest and Taxes (EBITDA)-6,398
 
After tax Income (+$)
Income Before Tax-33,067
Tax Provision-0
Net Income From Continuing Ops-13,269-33,067
Net Income-32,849
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses21,324
Total Other Income/Expenses Net-16,0825,109
 

Technical Analysis of Novo Integrated Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Novo Integrated Sciences Inc. The general trend of Novo Integrated Sciences Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Novo Integrated Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Novo Integrated Sciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.61 < 0.699 < 0.82.

The bearish price targets are: 0.43.

Tweet this
Novo Integrated Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Novo Integrated Sciences Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Novo Integrated Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Novo Integrated Sciences Inc. The current macd is -0.01932301.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Novo Integrated Sciences Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Novo Integrated Sciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Novo Integrated Sciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Novo Integrated Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartNovo Integrated Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Novo Integrated Sciences Inc. The current adx is 17.73.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Novo Integrated Sciences Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Novo Integrated Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Novo Integrated Sciences Inc. The current sar is 0.6407336.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Novo Integrated Sciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Novo Integrated Sciences Inc. The current rsi is 49.33. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Novo Integrated Sciences Inc Daily Relative Strength Index (RSI) ChartNovo Integrated Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Novo Integrated Sciences Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Novo Integrated Sciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Novo Integrated Sciences Inc Daily Stochastic Oscillator ChartNovo Integrated Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Novo Integrated Sciences Inc. The current cci is 57.88.

Novo Integrated Sciences Inc Daily Commodity Channel Index (CCI) ChartNovo Integrated Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Novo Integrated Sciences Inc. The current cmo is 3.27947947.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Novo Integrated Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartNovo Integrated Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Novo Integrated Sciences Inc. The current willr is -57.69230769.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Novo Integrated Sciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Novo Integrated Sciences Inc Daily Williams %R ChartNovo Integrated Sciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Novo Integrated Sciences Inc.

Novo Integrated Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Novo Integrated Sciences Inc. The current atr is 0.07901554.

Novo Integrated Sciences Inc Daily Average True Range (ATR) ChartNovo Integrated Sciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Novo Integrated Sciences Inc. The current obv is 234,357,334.

Novo Integrated Sciences Inc Daily On-Balance Volume (OBV) ChartNovo Integrated Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Novo Integrated Sciences Inc. The current mfi is 61.25.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Novo Integrated Sciences Inc Daily Money Flow Index (MFI) ChartNovo Integrated Sciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Novo Integrated Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Novo Integrated Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Novo Integrated Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.327
Ma 20Greater thanMa 500.491
Ma 50Greater thanMa 1000.575
Ma 100Greater thanMa 2000.747
OpenGreater thanClose0.500
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Novo Integrated Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Novo Integrated Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Novo Integrated Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Novo Integrated Sciences Inc

I send you an email if I find something interesting about Novo Integrated Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Novo Integrated Sciences Inc.

Receive notifications about Novo Integrated Sciences Inc in your mailbox!